About Us

Prostate cancer

Urothelial cancer

Epidemiology

Functional Urology

Andrology

Pediatric urology

People

Research Objectives

We investigate clinical, epidemiological, pathological, molecular and genetic characteristics of urological diseases. Our goal is to improve urological healthcare, from the general practitioner to tertiary academic care.

Collaborations

The Department of Urology of the Erasmus University Medical Center, Rotterdam, is embedded in the dynamic, internationally competitive research community of  several clinical, translational and basic research groups. Our focus lies in Protate Cancer, Urothelial Cancer, Functional Urology, Andrology and Pediatric Urology. We have longstandig collaborations with multiple other acadamic centers, both internationally and at a national level, and host fruitful relationships with our industry partners. Our department is renowed for participation at the highest level to improve European Patient Guidelines.

Academic Excellence

Our motto: “research” = care. We aim to improve the diagnosis, treatment and outcome in patients with urologic diseases by translational, clinical and epidemiological research, and education of students and professionals. Providing excellent academic care at a tertiary level is in our DNA. Do you want to be part of our team, either as as aspiring researcher or student, don’t hesitate to send your contact information to one of our Principal Investigators.

The Department of Urology is residing in the Staff Tower (Na building, 15th floor), the Erasmus MC Cancer Institute (Nt building, 2nd floor) and in the Josephine Nefkens Institute (Be-building, 3rd floor).

The Department Chair is Prof. Dr. Joost L. Boormans.

Latest news

New publication: Assessing the Cause of Death for Men with Prostate Cancer Using Official Mortality Statistics or a Dedicated Cause of Death Committee: Results from 30-year ERSPC Rotterdam Data

Sebastiaan Remmers, Ivo I de Vos, Frederique B Denijs, Renée C A Leenen, Tycho M T W Lock, Arjen Noordzij,...
Read More

New publication: Reducing Overtreatment of Prostate Cancer Patients: Revisiting the European Association of Urology Pretreatment Risk Group Classification Using Long-term Follow-up Data from the European Randomized Study of Screening for Prostate Cancer Rotterdam

Ivo I de Vos, Charlotte Rosenstand, Renée Hogenhout, Roderick C N van den Bergh, Sebastiaan Remmers, Monique J Roobol; ERSPC...
Read More

New publication: Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe

Pieter Vynckier, Lieven Annemans, Sarah Raes, Cheïma Amrouch, Peter Lindgren, Ondřej Májek, Katharina Beyer, Renée C A Leenen, Lionne D...
Read More

New publication: A Molecular Urine Assay to Detect Recurrences During Surveillance of High-Risk Non-Muscle Invasive Bladder Cancer

Joep J de Jong, Florus C de Jong, Angelique C J van der Made, Niels J van Casteren, Hossain Roshani,...
Read More

New publication: Bladder irrigation with tap water to reduce antibiotic use for urinary tract infections in catheter users

Stefan den Hoedt, Felice E E van Veen, Jeroen R Scheepe, Bertil F M Blok Link to publication: https://pubmed.ncbi.nlm.nih.gov/39414620/
Read More

New publication: Centralized prostatectomy with intraoperative NeuroSAFE margin assessment improves surgical margin control

Lisa J Kroon, Sebastiaan Remmers, Martijn B Busstra, Melanie Gan, Sjoerd Klaver, John B W Rietbergen, Margaretha A van der...
Read More

New publication: Standard Repeat Biopsies During Active Surveillance for Prostate Cancer: Are They Necessary in the Magnetic Resonance Imaging Era?

Roderick C N van den Bergh, Ivo G Schoots, Philip A Cornford; European Association of Urology Prostate Cancer Guidelines Panel...
Read More

New publication: Hereditary and Familial Traits in Urological Cancers and Their Underlying Genes

Kari Hemminki, Lambertus A Kiemeney, Alicia K Morgans, Antti Ranniko, Renate Pichler, Otto Hemminki, Zoran Culig, Peter Mulders, Chris H...
Read More

New publication: Characterization of Fibroblast Growth Factor Receptor Alterations and Activation in Patients with High-Risk Non-Muscle Invasive Bladder Cancer

Joel R Eisner, Florus C de Jong, Yoichiro Shibata, Gregory M Mayhew, James M Davison, Jenna Carcione, Kirk L Pappan,...
Read More

New publication: Risk of Progression of High-grade Primary T1 Non–muscle-invasive Bladder cancer in a Contemporary Cohort

Olga M. Pijpers, Lisa M.C. van Hoogstraten, Sebastiaan Remmers, Irene J. Beijert , Jorg R. Oddens , J. Alfred Witjes...
Read More

New publication: Adjustable continence therapy (ProACT/ACTTM) with periurethral balloons for treatment of stress urinary incontinence: a narrative review

den Hoedt S, Blok BFM. Link to article: https://pubmed.ncbi.nlm.nih.gov/39280649/
Read More

New publication: Are primary tumors suitable for biomarker-guided treatment of metastatic urothelial cancer?

Scholtes MP, van Leenders GJLH, Robbrecht DGJ, Boormans JL, Zuiverloon TCM. Link to article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11399036/
Read More

New publication: PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research

Ailbhe Lawlor, Katharina Beyer, Beth Russell, Carl Steinbeisser, Anders Bjartell, Bertrand De Meulder, Muhammad Imran Omar, Tim Hulsen, John Butler,...
Read More

New publication: Prostate Cancer Early Detection in the European Union and UK

Renée C.A. Leenen, Lionne D.F. Venderbos, Jozien Helleman, Juan Gómez Rivas, Pieter Vynckier c, Lieven Annemans, Renata Chloupková, Ondřej Májek,...
Read More

New publication: Centralized prostatectomy with intraoperative NeuroSAFE margin assessment improves surgical margin control

Lisa J Kroon, Sebastiaan Remmers, Martijn B Busstra, Melanie Gan, Sjoerd Klaver, John B W Rietbergen, Margaretha A van der...
Read More

New publication: Words of Wisdom. Re: EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.

JJ. de Jong, Y. Lotan, J.L. Boormans Article: WoW Eur Urol 2024
Read More

New publication: De-escalation of Monitoring in Active Surveillance for Prostate Cancer: Results from the GAP3 Consortium

Yoichiro Tohi, John M Sahrmann, Jaron Arbet, Takuma Kato, Lui Shiong Lee, Michael Peacock, Kevin Ginsburg Christian Pavlovich, Peter Carroll,...
Read More

New publication: Molecular biomarkers of progression in non-muscle-invasive bladder cancer – beyond conventional risk stratification

Mitchell Olislagers, Florus C de Jong, Vera C Rutten, Joost L Boormans, Tokameh Mahmoudi, Tahlita C M Zuiverloon Link to...
Read More

New publication: Understanding the Barriers to Prostate Cancer Population-Based Early Detection Programs: The PRAISE-U BEST Survey

Katharina Beyer, Renée C A Leenen, Lionne D F Venderbos, Jozien Helleman, Sebastiaan Remmers, Vera Vasilyeva, Juan Gomez Rivas, Erik...
Read More

New publication: From Screening to Mortality Reduction: An Overview of Empirical Data on the Patient Journey in European Randomized Study of Screening for Prostate Cancer Rotterdam After 21 Years of Follow-up and a Reflection on Quality of Life.

Renée Hogenhout, Sebastiaan Remmers, Marlies E van Slooten-Midderigh, Ivo I de Vos Monique J Roobol; ERSPC Rotterdam Study Group Link...
Read More

 

The full archive can be found by clicking here